OncoSec Medical Inc. is studying whether it can combine a drug and a medical device to defeat a rare cancer.

OncoSec Medical Inc. is studying whether it can combine a drug and a medical device to defeat a rare cancer.

ONCOSEC MEDICAL INC.

President and CEO: Punit Dhillon.

Revenue: Not generating revenue.

Net loss: $3.8 million in 2011; $36,158 in 2010.

No. of local employees: 11.

Headquarters: UTC area.

Year founded: 2008.

Stock symbol and exchange: ONCS on the OTC Bulletin Board.

Company description: A development-stage biomedical company that’s in clinical trials for drug-device combination products to treat types of cancer.

Key factors for success: The company acquired key technology from Inovio Pharmaceuticals Inc. in early 2011, which forms the basis of its product pipeline.

San Diego-based OncoSec Medical Inc...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129